Oing, Christoph; Giannatempo, Patrizia; Honecker, Friedemann; Oechsle, Karin; Bokemeyer, Carsten; Beyer, Jörg (2018). Palliative treatment of germ cell cancer. Cancer treatment reviews, 71, pp. 102-107. Elsevier 10.1016/j.ctrv.2018.10.007
|
Text
2018 Critical Reviews Oing.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (774kB) | Preview |
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Beyer, Jörg |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1532-1967 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
19 Mar 2019 13:12 |
Last Modified: |
05 Dec 2022 15:25 |
Publisher DOI: |
10.1016/j.ctrv.2018.10.007 |
PubMed ID: |
30415106 |
Uncontrolled Keywords: |
Drug therapy Germ cell cancer Germ cell tumor Palliative treatment Platinum-refractory |
BORIS DOI: |
10.7892/boris.124931 |
URI: |
https://boris.unibe.ch/id/eprint/124931 |
Actions (login required)
 |
Edit item |